Scarica l'app Stockscreener
22.22
2.03%
-0.46
Dopo l'orario di chiusura:
22.66
0.44
+1.98%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$22.68
Aprire:
$22.68
Volume 24 ore:
1.23M
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.02B
Reddito:
$203.27M
Utile/perdita netta:
$-4.66M
Rapporto P/E:
-222.20
EPS:
-0.1
Flusso di cassa netto:
$3.47M
1 W Prestazione:
+22.29%
1M Prestazione:
+24.55%
6M Prestazione:
+36.57%
1 anno Prestazione:
+58.71%
Intervallo 1D:
$21.68
$22.99
Intervallo di 1 settimana:
$17.14
$23.14
Portata 52W:
$9.215
$23.14
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Confronta AXGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
22.22 | 1.05B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | Lake Street | Buy |
| 2024-07-01 | Iniziato | Raymond James | Outperform |
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
Does Axogen Inc. show high probability of reboundWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Technical analysis overview for Axogen Inc. stock2025 Market Trends & Weekly Market Pulse Updates - newser.com
Y Intercept Hong Kong Ltd Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
How risky is Axogen Inc. stock nowVolume Spike & Precise Buy Zone Identification - newser.com
What drives Axogen Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in
AxoGen (NASDAQ:AXGN) Director Sells $826,829.25 in Stock - MarketBeat
Insider Selling: AxoGen (NASDAQ:AXGN) Director Sells 18,248 Shares of Stock - MarketBeat
Why Axogen (AXGN) Is Up 22.3% After Returning to Profitability and Raising 2025 Guidance - simplywall.st
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Axogen, Inc. Hits New 52-Week High of $22.95, Surges 217.86% - Markets Mojo
Axogen Stock Soars 23% to Intraday High Amid Strong Market Activity - Markets Mojo
Will Axogen Inc. stock gain from government policiesShort Setup & Advanced Technical Analysis Signals - newser.com
Axogen Reports Strong Q3 2025 Results, Raises Guidance - MSN
Axogen Insider Sold Shares Worth $1,246,717, According to a Recent SEC Filing - MarketScreener
Axogen Director William P. Burke Sells Over 58,000 Shares - TradingView
HC Wainwright Increases AxoGen (NASDAQ:AXGN) Price Target to $26.00 - MarketBeat
Axogen raises 2025 revenue growth target to at least 19% as BLA for Avance Nerve Graft nears key milestone - MSN
AxoGen (NASDAQ:AXGN) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
Citizens Jmp Issues Positive Forecast for AxoGen (NASDAQ:AXGN) Stock Price - MarketBeat
3 Stocks Estimated To Be Trading Below Their Fair Value In October 2025 - simplywall.st
What’s next for Axogen Inc. stock pricePortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Order flow analysis tools used on Axogen Inc.July 2025 Trends & Real-Time Chart Breakout Alerts - newser.com
What the charts say about Axogen Inc. today2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Is Axogen Inc. stock attractive after correction2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Is Axogen Inc. stock ready for a breakout2025 Market Overview & Expert Curated Trade Ideas - newser.com
How buybacks impact Axogen Inc. stock valueWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Axogen, Inc. (AXGN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Citizens Maintains Axogen (AXGN) Market Outperform Recommendation - Nasdaq
Raymond James Maintains Axogen (AXGN) Outperform Recommendation - Nasdaq
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - Yahoo Finance
Axogen (AXGN): HC Wainwright & Co. Raises Price Target to $26 | - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners - Investing.com Australia
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Reven - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners By Investing.com - Investing.com South Africa
AXGN: Raymond James Raises Price Target for Axogen to $27.00 | A - GuruFocus
AxoGen (NASDAQ:AXGN) Announces Quarterly Earnings Results - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 1-Year HighShould You Buy? - MarketBeat
AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Multi factor analysis applied to Axogen Inc.Weekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Is Axogen About To Hit A Clinical Nerve With Avance Approval? - RTTNews
Citizens raises AxoGen stock price target to $34 on differentiated products By Investing.com - Investing.com South Africa
Citizens raises AxoGen stock price target to $34 on differentiated products - Investing.com
Price action breakdown for Axogen Inc.Weekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
AxoGen Q3 2025 Earnings Preview - MSN
Axogen, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AXGN) 2025-10-30 - Seeking Alpha
Axogen Inc earnings beat by $0.05, revenue topped estimates - Investing.com Canada
AxoGen: Q3 Earnings Snapshot - Stamford Advocate
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):